Insider Transactions in Q2 2023 at Phreesia, Inc. (PHR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 10
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
63
-1.09%
|
$1,890
$30.15 P/Share
|
|
Apr 10
2023
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Indirect |
210
+3.5%
|
-
|
|
Apr 10
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,800
-0.86%
|
$54,000
$30.15 P/Share
|
|
Apr 10
2023
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
4,248
+1.99%
|
-
|
|
Apr 03
2023
|
Mark Douglas Smith Director |
SELL
Open market or private sale
|
Direct |
7,000
-15.57%
|
$217,000
$31.23 P/Share
|
|
Apr 03
2023
|
Mark Douglas Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+23.25%
|
$28,000
$4.71 P/Share
|
|
Apr 03
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
2,978
-1.5%
|
$92,318
$31.19 P/Share
|